CCL2 and neoplasm: Upon being recruited to inflammatory tumor tissues in response to chemokines like CCL2, CCL5, CXCL8, and CXCL12, MDSCs rapidly produce immunosuppressive mediators, including ARG1, NO, TGF-β, and IL-10, which further impair anti-tumor immunity [174,175].